Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Catherine Quynh Nhu Nguyen, Liwei Ma, Yi Ling Clare Low, Edwin C. K. Tan, Christopher Fowler, Colin L. Masters, Liang Jin, Yijun Pan |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
por: Chloe Walsh, et al.
Publicado: (2026)
por: Chloe Walsh, et al.
Publicado: (2026)
Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
por: Ying Xia, et al.
Publicado: (2025)
por: Ying Xia, et al.
Publicado: (2025)
Multilevel prediction of Alzheimer's disease dementia in the United States: An artificial intelligence analysis
por: Nicolaas P. Pronk, et al.
Publicado: (2026)
por: Nicolaas P. Pronk, et al.
Publicado: (2026)
Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
por: Lay Kodama, et al.
Publicado: (2026)
por: Lay Kodama, et al.
Publicado: (2026)
Underlying brain and genetic mechanisms linking historic phone use patterns, visual decline, and dementia risk in middle‐aged and older adults
por: Xiayin Zhang, et al.
Publicado: (2025)
por: Xiayin Zhang, et al.
Publicado: (2025)
Inter‐scanner Aβ‐PET harmonization using barrel phantom spatial resolution matching
por: Gihan P. Ruwanpathirana, et al.
Publicado: (2024)
por: Gihan P. Ruwanpathirana, et al.
Publicado: (2024)
Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
por: David Foxe, et al.
Publicado: (2024)
por: David Foxe, et al.
Publicado: (2024)
Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
por: John T. O'Brien
Publicado: (2025)
por: John T. O'Brien
Publicado: (2025)
Navigating late‐stage dementia: A perspective from the Alzheimer's Association
por: Kristen Clifford, et al.
Publicado: (2024)
por: Kristen Clifford, et al.
Publicado: (2024)
Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
por: Darren M. Lipnicki, et al.
Publicado: (2026)
por: Darren M. Lipnicki, et al.
Publicado: (2026)
Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
por: Willa D. Brenowitz, et al.
Publicado: (2026)
por: Willa D. Brenowitz, et al.
Publicado: (2026)
Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
por: Cassandra Marotta, et al.
Publicado: (2025)
por: Cassandra Marotta, et al.
Publicado: (2025)
Vocal expression of emotions discriminates dementia with Lewy bodies from Alzheimer's disease
por: Masatomo Kobayashi, et al.
Publicado: (2024)
por: Masatomo Kobayashi, et al.
Publicado: (2024)
Examining the propensity and nature of criminal risk behaviours in frontotemporal dementia syndromes and Alzheimer's disease
por: Fiona Kumfor, et al.
Publicado: (2024)
por: Fiona Kumfor, et al.
Publicado: (2024)
α‐Synuclein seed amplification assay in Lewy body dementia versus Alzheimer's disease
por: Oskar H. McWilliam, et al.
Publicado: (2025)
por: Oskar H. McWilliam, et al.
Publicado: (2025)
Microstructural alterations in the locus coeruleus‐entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia
por: Giulia Quattrini, et al.
Publicado: (2024)
por: Giulia Quattrini, et al.
Publicado: (2024)
Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
por: Sean A. P. Clouston, et al.
Publicado: (2025)
por: Sean A. P. Clouston, et al.
Publicado: (2025)
Neurology and inflammatory‐associated plasma protein biomarkers linked to dementia progression, brain aging pathology
por: Noah Schweitzer, et al.
Publicado: (2026)
por: Noah Schweitzer, et al.
Publicado: (2026)
Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
por: María A. Rodríguez‐Santiago, et al.
Publicado: (2024)
por: María A. Rodríguez‐Santiago, et al.
Publicado: (2024)
Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
por: Fang Wang, et al.
Publicado: (2025)
por: Fang Wang, et al.
Publicado: (2025)
A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions
por: Ananthan Ambikairajah, et al.
Publicado: (2025)
por: Ananthan Ambikairajah, et al.
Publicado: (2025)
Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
por: Iolanda Lázaro, et al.
Publicado: (2024)
por: Iolanda Lázaro, et al.
Publicado: (2024)
Letter response to Clifford et al. “Navigating late‐stage dementia: A perspective from the Alzheimer's Association”
por: Stanley Arnold Terman, et al.
Publicado: (2024)
por: Stanley Arnold Terman, et al.
Publicado: (2024)
Fully automated MRI‐based analysis of the locus coeruleus in aging and Alzheimer's disease dementia using ELSI‐Net
por: Max Dünnwald, et al.
Publicado: (2025)
por: Max Dünnwald, et al.
Publicado: (2025)
Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
por: Gustavo Luis Verón, et al.
Publicado: (2025)
por: Gustavo Luis Verón, et al.
Publicado: (2025)
A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
por: Sara Teijeira‐Portas, et al.
Publicado: (2026)
por: Sara Teijeira‐Portas, et al.
Publicado: (2026)
Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
por: Jessie T. Yan, et al.
Publicado: (2025)
por: Jessie T. Yan, et al.
Publicado: (2025)
Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
por: Faheem Arshad, et al.
Publicado: (2025)
por: Faheem Arshad, et al.
Publicado: (2025)
Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
por: Yuhan Xie, et al.
Publicado: (2025)
por: Yuhan Xie, et al.
Publicado: (2025)
Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
por: Dejia Yin, et al.
Publicado: (2026)
por: Dejia Yin, et al.
Publicado: (2026)
Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
por: Frédéric Blanc, et al.
Publicado: (2025)
por: Frédéric Blanc, et al.
Publicado: (2025)
Detecting time‐varying genetic effects in Alzheimer's disease using a longitudinal genome‐wide association studies model
por: Xiaowei Zhuang, et al.
Publicado: (2024)
por: Xiaowei Zhuang, et al.
Publicado: (2024)
Awareness, attitudes, and beliefs of dementia in Indonesia
por: Nicolas Farina, et al.
Publicado: (2024)
por: Nicolas Farina, et al.
Publicado: (2024)
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
por: Nicholas R. Ray, et al.
Publicado: (2024)
por: Nicholas R. Ray, et al.
Publicado: (2024)
A scoping review of dementia education programs for Chinese, Japanese, Korean, Filipino, and Vietnamese communities
por: Diana Karamacoska, et al.
Publicado: (2026)
por: Diana Karamacoska, et al.
Publicado: (2026)
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
por: Samantha C. Burnham, et al.
Publicado: (2026)
por: Samantha C. Burnham, et al.
Publicado: (2026)
Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
por: Andrée‐Ann Baril, et al.
Publicado: (2024)
por: Andrée‐Ann Baril, et al.
Publicado: (2024)
The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
por: Kathryn A. Wyman‐Chick, et al.
Publicado: (2024)
por: Kathryn A. Wyman‐Chick, et al.
Publicado: (2024)
Incidence of young‐onset dementia in Italy: The Brescia register study
por: Barbara Borroni, et al.
Publicado: (2024)
por: Barbara Borroni, et al.
Publicado: (2024)
Genetic associations of plasma proteomics with dementia subtypes and neuroimaging markers
por: Ahmed M. Salih, et al.
Publicado: (2025)
por: Ahmed M. Salih, et al.
Publicado: (2025)
Ejemplares similares
-
Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
por: Chloe Walsh, et al.
Publicado: (2026) -
Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
por: Ying Xia, et al.
Publicado: (2025) -
Multilevel prediction of Alzheimer's disease dementia in the United States: An artificial intelligence analysis
por: Nicolaas P. Pronk, et al.
Publicado: (2026) -
Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
por: Lay Kodama, et al.
Publicado: (2026) -
Underlying brain and genetic mechanisms linking historic phone use patterns, visual decline, and dementia risk in middle‐aged and older adults
por: Xiayin Zhang, et al.
Publicado: (2025)